Ann: FDA Approves Sofdra, page-308

I've read this type of post after every single raise they've done. The truth is we don't know their capital needs, but they've done pretty well so far so I trust them to raise what they need to in order to turn this into the company we all hope it'll become. I would actually be betting on another even larger raise down the track given the size of their pipeline and their enormous ambitions.

Raises are not inherently a bad thing, they're the cost to achieving great success. Done properly they deliver significantly greater returns to investors than would otherwise have been possible.